626 Financial, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

626 Financial, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 11, 2024	SELL	$1.26 - $1.79 $1,794 - $2,548	-1,424 Reduced 6.93%	19,112 $32,000
Q3 2023 Oct 11, 2023	SELL	$1.61 - $2.54 $75,670 - $119,380	-47,000 Reduced 69.59%	20,536 $37,000
Q2 2023 Jul 14, 2023	SELL	$1.14 - $1.95 $3,677 - $6,290	-3,226 Reduced 4.56%	67,536 $125,000
Q1 2023 Apr 12, 2023	BUY	$1.2 - $2.19 $29,298 - $53,468	24,415 Added 52.68%	70,762 $94,000
Q4 2022 Jan 24, 2023	SELL	$1.63 - $3.52 $4,909 - $10,602	-3,012 Reduced 6.1%	46,347 $0
Q3 2022 Oct 21, 2022	BUY	$0.73 - $3.74 $16 - $86	23 Added 0.05%	49,359 $154,000
Q2 2022 Jul 12, 2022	BUY	$2.2 - $4.2 $108,539 - $207,211	49,336 New	49,336 $118,000
Q1 2022 May 05, 2022	SELL	$2.83 - $8.69 $70,399 - $216,172	-24,876 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.31 - $14.92 $206,719 - $371,149	24,876 New	24,876 $207,000

48M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $19B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of 626 Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on 626 Financial, LLC with notifications on news.